MEDIA STATEMENT • MEDIA STATEMENT • MEDIA STATEMENT Investigational heart failure medicine LCZ696 (sacubitril valsartan) receives Promising Innovative Medicine designation in the UK PIM designation is the first s - prodrugs - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-04-22 09:44:53 Organic chemistry Amides Novartis Carboxylic acids Heart diseases Valsartan Heart failure Enalapril LCZ696 Chemistry Pharmacology ACE inhibitors		MEDIA STATEMENT • MEDIA STATEMENT • MEDIA STATEMENT Investigational heart failure medicine LCZ696 (sacubitril/valsartan) receives Promising Innovative Medicine designation in the UK PIM designation is the first s Add to Reading List Source URL: preview.thenewsmarket.com Download Document from Source Website File Size: 191,86 KB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document